Status:
UNKNOWN
L-Gastrectomy With the Intelligent Navigation 4K UHD 3D Endoscopic Imaging System
Lead Sponsor:
Shanghai Minimally Invasive Surgery Center
Conditions:
Stomach Neoplasms
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study aims to evaluate the safety, efficacy, and feasibility of the Intelligent Navigation 4K UHD 3D Endoscopic Imaging System in patients with gastric cancer.
Detailed Description
Background: Lymphadenectomy in laparoscopic gastrectomy can significantly improve the long-term survival and accuracy of the tumor staging of patients with gastric cancer. The retrieval of more lymph ...
Eligibility Criteria
Inclusion
- Diagnosed with gastric cancer require surgery;
- Without a history of abdominal surgery;
- BMI ≤ 30 kg/m2;
- Preoperative ECOG score is 0\~1 and ASA score is I\~III;
- Having signed the Medical Informed Consent.
Exclusion
- Patients with metastasis or invasion of surrounding tissues;
- Undergoing emergency operation (perforation, hemorrhage, obstruction);
- Patients with serious medical co-morbidity (heart, lung, liver and kidney diseases) and could not tolerate laparoscopic surgery;
- With poor incorrigible physical condition before surgery;
- The patient who underwent gastrojejunostomy or jejunostomy;
- The patient who refuses to accept standardized postoperative systemic therapy according to the guidelines.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT04526483
Start Date
October 1 2020
End Date
October 1 2022
Last Update
August 25 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.